*:@0.049468:0.836031:0.052905:0.836031:0.052905:0.824571:0.049468:0.824571:0.003437
Natural elegance: In the APPEAL survey, subjects responded that after Dysport  injections, they experienced different feelings,  :@0.067373:0.836031:0.564625:0.836031:0.564625:0.824571:0.067373:0.824571:0.006378:0.004913:0.002456:0.004913:0.002941:0.004913:0.001961:0.002338:0.004913:0.001961:0.004913:0.004913:0.004913:0.004913:0.004417:0.004913:0.002456:0.002338:0.002456:0.004913:0.002338:0.002456:0.004913:0.004913:0.001853:0.005893:0.005893:0.005893:0.005893:0.005893:0.004589:0.002338:0.004417:0.004913:0.002941:0.004417:0.004913:0.003771:0.002456:0.002338:0.004417:0.004913:0.004913:0.001961:0.004913:0.004417:0.002456:0.004417:0.002338:0.002941:0.004913:0.004417:0.004913:0.004913:0.004913:0.004913:0.004913:0.004913:0.002338:0.002456:0.004913:0.004913:0.002456:0.002338:0.004913:0.002456:0.002456:0.004913:0.002941:0.002338:0.006378:0.004417:0.004417:0.004913:0.004913:0.002941:0.002456:0.003776:0.002338:0.001961:0.004913:0.001961:0.004913:0.004417:0.002456:0.001961:0.004913:0.004913:0.004417:0.002456:0.002338:0.002456:0.004913:0.004913:0.004417:0.002338:0.004913:0.004417:0.004913:0.004913:0.002941:0.001961:0.004913:0.004913:0.004417:0.004913:0.004913:0.002338:0.004913:0.001961:0.002305:0.002456:0.004913:0.002941:0.004913:0.004913:0.002456:0.002338:0.002456:0.004913:0.004913:0.001961:0.001961:0.004913:0.004913:0.004417:0.002456:0.002348:0.002456
®:@0.375565:0.832238:0.379359:0.832238:0.379359:0.825557:0.375565:0.825557:0.003794
including more harmony, self-esteem, youth, beauty, and symmetrical appearance.:@0.067368:0.845632:0.388710:0.845632:0.388710:0.834172:0.067368:0.834172:0.001961:0.004913:0.004417:0.001961:0.004913:0.004913:0.001961:0.004913:0.004913:0.002338:0.007358:0.004913:0.002941:0.004913:0.002338:0.004913:0.004913:0.002941:0.007358:0.004913:0.004913:0.003771:0.002456:0.002338:0.004417:0.004913:0.001961:0.002456:0.002941:0.004913:0.004417:0.002456:0.004913:0.004913:0.007358:0.002456:0.002338:0.004417:0.004913:0.004913:0.002456:0.004913:0.002456:0.002338:0.004913:0.004913:0.004913:0.004913:0.002456:0.003771:0.002456:0.002338:0.004913:0.004913:0.004913:0.002338:0.004417:0.004417:0.007358:0.007358:0.004913:0.002456:0.002941:0.001961:0.004417:0.004913:0.001961:0.002338:0.004913:0.004913:0.004913:0.004913:0.004913:0.002941:0.004913:0.004913:0.004417:0.004913:0.002456
4:@0.388725:0.841836:0.391589:0.841836:0.391589:0.835155:0.388725:0.835155:0.002864
*:@0.432556:0.389432:0.444673:0.389432:0.444673:0.355315:0.432556:0.355315:0.012116
 S4  Dysport Each vial contains 500 U of :@0.052375:0.936436:0.227647:0.936436:0.227647:0.923927:0.052375:0.923927:0.002681:0.006432:0.005362:0.002681:0.002681:0.006961:0.004821:0.004821:0.005362:0.005362:0.003210:0.002681:0.002681:0.006432:0.005362:0.004821:0.005362:0.002681:0.004821:0.002140:0.005362:0.002140:0.002681:0.004821:0.005362:0.005362:0.002681:0.005362:0.002140:0.005362:0.004821:0.002681:0.005362:0.005362:0.005362:0.002681:0.006961:0.002681:0.005362:0.002681:0.002681
Clostridium botulinum:@0.227224:0.936436:0.319922:0.936436:0.321934:0.923927:0.229235:0.923927:0.006961:0.002140:0.005362:0.004821:0.002681:0.003210:0.002140:0.005362:0.002140:0.005362:0.008032:0.002681:0.005362:0.005362:0.002681:0.005362:0.002140:0.002140:0.005362:0.005362:0.010043
 type A toxin-haemagglutinin complex. Excipients: Human albumin solution, lactose. :@0.320380:0.936436:0.679026:0.936436:0.679026:0.923927:0.320380:0.923927:0.002681:0.002681:0.004821:0.005362:0.005362:0.002152:0.005903:0.002681:0.002681:0.005362:0.004821:0.002140:0.005362:0.003210:0.005362:0.005362:0.005362:0.008032:0.005362:0.005362:0.005362:0.002140:0.005362:0.002681:0.002140:0.005362:0.002140:0.005362:0.002681:0.004821:0.005362:0.008032:0.005362:0.002140:0.005362:0.004821:0.002681:0.002681:0.006432:0.004821:0.004821:0.002140:0.005362:0.002140:0.005362:0.005362:0.002681:0.004821:0.002681:0.002681:0.006961:0.005362:0.008032:0.005362:0.005362:0.002681:0.005362:0.002140:0.005362:0.005362:0.008032:0.002140:0.005362:0.002681:0.004821:0.005362:0.002140:0.005362:0.002681:0.002140:0.005362:0.005362:0.002681:0.002681:0.002140:0.005362:0.004821:0.002681:0.005362:0.004821:0.005362:0.002752:0.002681
 Reg No.: 37/30.4/0683. Applicant: Litha Pharma (Pty) Ltd. Reg. no. 1994/008717/07. LP2761 05/2019.:@0.052375:0.947984:0.491466:0.947984:0.491466:0.935475:0.052375:0.935475:0.002681:0.006961:0.005362:0.005362:0.002681:0.006961:0.005362:0.002681:0.002681:0.002681:0.005362:0.005362:0.002681:0.005362:0.005362:0.002681:0.005362:0.002681:0.005362:0.005362:0.005362:0.005362:0.002681:0.002164:0.006432:0.005362:0.005362:0.002140:0.002140:0.004821:0.005362:0.005362:0.002681:0.002681:0.002681:0.005362:0.002140:0.002681:0.005362:0.005362:0.002681:0.006432:0.005362:0.005362:0.003210:0.008032:0.005362:0.002681:0.003210:0.006432:0.002681:0.004821:0.003210:0.002681:0.005362:0.002681:0.005362:0.002681:0.002681:0.006961:0.005362:0.005362:0.002681:0.002681:0.005362:0.005362:0.002681:0.002681:0.005362:0.005362:0.005362:0.005362:0.002681:0.005362:0.005362:0.005362:0.005362:0.005362:0.005362:0.002681:0.005362:0.005362:0.002681:0.002681:0.005362:0.006432:0.005362:0.005362:0.005362:0.005362:0.002681:0.005362:0.005362:0.002681:0.005362:0.005362:0.005362:0.005362:0.002681
DYSPORT:@0.074550:0.648330:0.241093:0.648330:0.241093:0.615528:0.074550:0.615528:0.024183:0.022934:0.021512:0.022483:0.028798:0.024149:0.022483
® :@0.240399:0.648892:0.266158:0.648892:0.266158:0.613238:0.240399:0.613238:0.014444:0.011314
OFFERS::@0.266158:0.648892:0.429458:0.648892:0.429458:0.613238:0.266158:0.613238:0.031302:0.023986:0.023986:0.024514:0.026513:0.023382:0.009617
HIGH PATIENT  :@0.089587:0.726410:0.227412:0.726410:0.227412:0.709791:0.089587:0.709791:0.013361:0.005116:0.013783:0.013361:0.005274:0.010513:0.012306:0.011392:0.005116:0.011778:0.013888:0.011392:0.005274:0.005274
SATISFACTION:@0.084682:0.742520:0.217339:0.742520:0.217339:0.725900:0.084682:0.725900:0.010987:0.012306:0.011392:0.005116:0.011251:0.010126:0.013167:0.012974:0.011392:0.005116:0.014943:0.013888
 1:@0.217334:0.736683:0.221772:0.736683:0.221772:0.726994:0.217334:0.726994:0.000769:0.003669
LONG LASTING :@0.420939:0.726410:0.563968:0.726410:0.563968:0.709791:0.420939:0.709791:0.010179:0.014943:0.013888:0.013783:0.005274:0.010882:0.013642:0.010987:0.011392:0.005116:0.013888:0.013783:0.005274
RESULTS :@0.445339:0.742520:0.527243:0.742520:0.527243:0.725900:0.445339:0.725900:0.012710:0.011778:0.011251:0.013343:0.009124:0.011128:0.011251:0.001319
 3:@0.527241:0.736683:0.534293:0.736683:0.534293:0.726994:0.527241:0.726994:0.000769:0.006283
FAST  :@0.299430:0.726410:0.356124:0.726410:0.356124:0.709791:0.299430:0.709791:0.010126:0.013642:0.010987:0.011392:0.005274:0.005274
ONSET :@0.286772:0.742520:0.351343:0.742520:0.351343:0.725900:0.286772:0.725900:0.014943:0.013888:0.011251:0.011778:0.011392:0.001319
 2:@0.351334:0.736683:0.358242:0.736683:0.358242:0.726994:0.351334:0.726994:0.000769:0.006139
References: :@0.052375:0.875416:0.105622:0.875416:0.105622:0.862121:0.052375:0.862121:0.006440:0.004935:0.002910:0.004935:0.003419:0.004935:0.005433:0.004935:0.004935:0.004935:0.002910:0.002523
1. Molina B, et al. Patient satisfaction after the treatment of glabellar lines with Botulinum toxin type A (Speywood Unit): a multi-centre European :@0.105777:0.875416:0.673368:0.875416:0.673368:0.862337:0.105777:0.862337:0.004935:0.002412:0.002678:0.007447:0.004935:0.001903:0.001903:0.004935:0.004935:0.002678:0.005942:0.002412:0.002678:0.004935:0.002412:0.002678:0.004935:0.001903:0.002412:0.002678:0.005942:0.004935:0.002412:0.001903:0.004935:0.004935:0.002412:0.002678:0.004426:0.004935:0.002412:0.001903:0.004426:0.002412:0.004935:0.004426:0.002412:0.001903:0.004935:0.004935:0.002678:0.004935:0.002412:0.002412:0.004935:0.002910:0.002678:0.002412:0.004935:0.004935:0.002678:0.002412:0.002910:0.004935:0.004935:0.002412:0.007447:0.004935:0.004935:0.002412:0.002678:0.004935:0.002412:0.002678:0.004935:0.001903:0.004935:0.004935:0.004935:0.001903:0.001903:0.004935:0.002910:0.002678:0.001903:0.001903:0.004935:0.004935:0.004426:0.002678:0.006440:0.001903:0.002412:0.004935:0.002678:0.005942:0.004935:0.002412:0.004935:0.001903:0.001903:0.004935:0.004935:0.007447:0.002678:0.002412:0.004935:0.004426:0.001903:0.004935:0.002678:0.002412:0.004426:0.004935:0.004935:0.002180:0.005444:0.002678:0.002910:0.005942:0.004935:0.004935:0.004426:0.006440:0.004935:0.004935:0.004935:0.002678:0.006440:0.004935:0.001903:0.002412:0.002910:0.002412:0.002678:0.004935:0.002678:0.007447:0.004935:0.001903:0.002412:0.001903:0.002910:0.004426:0.004935:0.004935:0.002412:0.002910:0.004935:0.002678:0.005942:0.004935:0.002910:0.004935:0.004935:0.004935:0.004935:0.005046:0.002523
observational study. J Eur Acad Dermatol Venereol. 2015 Jul;29(7):1382-8. doi:10.1111/jdv.12881. Epub 2014 Dec 12.  2. Moy R. et al. Long-term Safety and :@0.052375:0.886373:0.673358:0.886373:0.673358:0.873294:0.052375:0.873294:0.004935:0.004935:0.004426:0.004935:0.002910:0.004426:0.004935:0.002412:0.001903:0.004935:0.004935:0.004935:0.001903:0.002733:0.004426:0.002412:0.004935:0.004935:0.003762:0.002412:0.002733:0.004426:0.002733:0.005942:0.004935:0.002910:0.002235:0.005942:0.004426:0.004935:0.004935:0.002733:0.006440:0.004935:0.002910:0.007447:0.004935:0.002412:0.004935:0.001903:0.002733:0.005444:0.004935:0.004935:0.004935:0.002910:0.004935:0.004935:0.001903:0.002412:0.002733:0.004935:0.004935:0.004935:0.004935:0.002733:0.004426:0.004935:0.001903:0.002412:0.004935:0.004935:0.002910:0.004935:0.002910:0.002412:0.004935:0.004935:0.004935:0.004935:0.002910:0.004935:0.002412:0.002733:0.004935:0.004935:0.001903:0.002412:0.004935:0.004935:0.002412:0.004271:0.004271:0.004271:0.004935:0.002412:0.001903:0.004935:0.003762:0.002412:0.004935:0.004935:0.004935:0.004935:0.004935:0.002412:0.002733:0.005942:0.004935:0.004935:0.004935:0.002733:0.004935:0.004935:0.004935:0.004935:0.002733:0.006440:0.004935:0.004426:0.002733:0.004935:0.004935:0.002412:0.002733:0.002733:0.004935:0.002412:0.002733:0.007447:0.004935:0.004426:0.002733:0.006440:0.002412:0.002733:0.004935:0.002412:0.002733:0.004935:0.001903:0.002412:0.002733:0.004935:0.004935:0.004935:0.004935:0.002910:0.002412:0.004935:0.002910:0.007447:0.002733:0.005942:0.004935:0.002412:0.004935:0.002412:0.004426:0.002733:0.004935:0.004935:0.005046:0.002523
Efficacy of a New Botulinum Toxin Type A in Treating Glabellar Lines Arch Facial Plast Surg. 2009;11:77-83. 3.Brandt F, Swanson N, Baumann L, Huber B. :@0.052375:0.897329:0.673391:0.897329:0.673391:0.884251:0.052375:0.884251:0.005942:0.002412:0.002213:0.002213:0.004426:0.004935:0.004426:0.004426:0.003076:0.004935:0.002412:0.003076:0.004935:0.003076:0.006440:0.004935:0.006440:0.003076:0.005942:0.004935:0.002412:0.004935:0.001903:0.001903:0.004935:0.004935:0.007447:0.002921:0.004426:0.004935:0.004426:0.001903:0.004935:0.002921:0.004935:0.004426:0.004935:0.004935:0.002578:0.005444:0.003076:0.001903:0.004935:0.002921:0.005101:0.002910:0.004935:0.004935:0.002412:0.001903:0.004935:0.004935:0.003076:0.006949:0.001903:0.004935:0.004935:0.004935:0.001903:0.001903:0.004935:0.002910:0.003076:0.004935:0.001903:0.004935:0.004935:0.004426:0.002578:0.005942:0.002910:0.004426:0.004935:0.003076:0.005433:0.004935:0.004426:0.001903:0.004935:0.001903:0.003076:0.005942:0.001903:0.004935:0.004426:0.002412:0.003076:0.005942:0.004935:0.002910:0.004935:0.002412:0.003076:0.004935:0.004935:0.004935:0.004935:0.002412:0.004271:0.004935:0.002412:0.004935:0.004935:0.002910:0.004935:0.004935:0.002412:0.003076:0.004935:0.002412:0.005942:0.002910:0.004935:0.004935:0.004935:0.002412:0.003076:0.004426:0.002412:0.003076:0.005942:0.006440:0.004935:0.004935:0.004426:0.004935:0.004935:0.003076:0.006440:0.002412:0.003076:0.005942:0.004935:0.004935:0.007447:0.004935:0.004935:0.004935:0.003076:0.004935:0.002412:0.003076:0.006440:0.004935:0.004935:0.004935:0.002910:0.003076:0.005942:0.002523:0.002523
Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: efficacy and safety. Dermatol Surg. 2009;35(12):1893-901. :@0.052375:0.908286:0.673258:0.908286:0.673258:0.895207:0.052375:0.895207:0.006440:0.004935:0.004935:0.004935:0.004935:0.007447:0.001903:0.004426:0.004935:0.004935:0.002412:0.001981:0.004935:0.001903:0.004935:0.004426:0.004935:0.004935:0.004935:0.002910:0.004426:0.004935:0.004935:0.002412:0.002910:0.004935:0.001903:0.001903:0.004935:0.004935:0.001981:0.004426:0.002412:0.004935:0.004935:0.004426:0.001981:0.004935:0.002412:0.001981:0.004935:0.001981:0.004935:0.004935:0.006440:0.001981:0.004935:0.004935:0.002412:0.004935:0.001903:0.001903:0.004935:0.004935:0.007447:0.001981:0.002412:0.004935:0.004426:0.001903:0.004935:0.001981:0.002412:0.004426:0.004935:0.004935:0.001494:0.005444:0.001981:0.002412:0.004935:0.002910:0.001981:0.002412:0.002910:0.004935:0.004935:0.002412:0.007447:0.004935:0.004935:0.002412:0.001981:0.004935:0.002412:0.001981:0.004935:0.001903:0.004935:0.004935:0.004935:0.001903:0.001903:0.004935:0.002910:0.001981:0.001903:0.001903:0.004935:0.004935:0.004426:0.002412:0.001981:0.004935:0.002412:0.002213:0.002213:0.004426:0.004935:0.004426:0.004426:0.001981:0.004935:0.004935:0.004935:0.001981:0.004426:0.004935:0.002412:0.004935:0.002412:0.003762:0.002412:0.001981:0.006440:0.004935:0.002910:0.007447:0.004935:0.002412:0.004935:0.001903:0.001992:0.005942:0.004935:0.002910:0.004935:0.002412:0.001981:0.004935:0.004935:0.004935:0.004935:0.002412:0.004935:0.004935:0.002910:0.004935:0.004935:0.002910:0.002412:0.004935:0.004935:0.004935:0.004935:0.002910:0.004935:0.004935:0.004935:0.002523:0.002523
CLOSTRIDIUM BOTULINUM TOXIN TYPE A:@0.774749:0.867647:0.938477:0.867647:0.938477:0.857091:0.774749:0.857091:0.005875:0.004525:0.006332:0.005429:0.004972:0.005875:0.002263:0.005875:0.002263:0.005875:0.006778:0.002263:0.005429:0.006332:0.004972:0.005875:0.004525:0.002263:0.005875:0.005875:0.006778:0.002124:0.004833:0.006332:0.005429:0.002263:0.005875:0.002124:0.004972:0.005429:0.005429:0.005429:0.001816:0.005429
COMBINED DYSPORT ADVERT MIMS 6June 2019.indd   1:@0.025791:1.016650:0.295777:1.016650:0.295777:1.008128:0.025791:1.008128:0.007277:0.007842:0.008396:0.006723:0.002802:0.007277:0.006723:0.007277:0.002802:0.007277:0.006723:0.006723:0.006723:0.007842:0.007277:0.006158:0.002802:0.006723:0.007277:0.006723:0.006723:0.007277:0.006158:0.002802:0.008396:0.002802:0.008396:0.006723:0.002802:0.005604:0.005040:0.005604:0.005604:0.005604:0.002802:0.005604:0.005604:0.005604:0.005604:0.002802:0.002238:0.005604:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604
2019/06/06   09:32:@0.918277:1.016650:1.002339:1.016650:1.002339:1.008128:0.918277:1.008128:0.005604:0.005604:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.005604:0.005604:0.002802:0.002802:0.002802:0.005604:0.005604:0.002802:0.005604:0.005604